Bisphosphonates cause osteonecrosis of the jaw-like disease in mice. - Wikidata - wikimedia - TriplyDB

Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.

Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.

http://www.wikidata.org/entity/Q33947252

about

Potential pathophysiological mechanisms in osteonecrosis of the jaw.Site specific effects of zoledronic acid during tibial and mandibular fracture repair.Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw.Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw.Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection.Bisphosphonate uptake in areas of tooth extraction or periapical disease Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease.Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.A novel model of bisphosphonate-related osteonecrosis of the jaw in rats The effect of the duration of intravenous zolendronate medication on the success of non-surgical endodontic therapy: a retrospective study.Osteomalacia: the missing link in the pathogenesis of bisphosphonate-related osteonecrosis of the jaws?Influence of bisphosphonate treatment on medullary macrophages and osteoclasts: an experimental study.Odanacatib, A Cathepsin K-Specific Inhibitor, Inhibits Inflammation and Bone Loss Caused by Periodontal Diseases Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: role in osteoclast-mediated NK cell activation.Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat.Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents.Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.Pathophysiology of Osteonecrosis of the Jaws.Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.Effect of alendronate on bone remodeling around implant in the rat.Activated protein C accelerates venous thrombus resolution through heme oxygenase-1 induction Skeletal Site-specific Effects of Zoledronate on in vivo Bone Remodeling and in vitro BMSCs Osteogenic Activity Dental extraction following zoledronate, induces osteonecrosis in rat's jaw.Animal models for bisphosphonate-related osteonecrosis of the jaws--an appraisal.Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents.Effects of alendronate on the peri-implant bone in rats.Effect of alendronate on healing of extraction sockets and healing around implants.Hyperbaric oxygen therapy and osteonecrosis.Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis.Osteonecrosis of the Jaw-a Bone Site-Specific Effect of Bisphosphonates.Lithium chloride enhances bone regeneration and implant osseointegration in osteoporotic conditions.Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model.Stage 0 osteonecrosis of the jaw in a patient on denosumab.IL-36 Induces Bisphosphonate-Related Osteonecrosis of the Jaw-Like Lesions in Mice by Inhibiting TGF-β-Mediated Collagen Expression.Treatment of central giant cell lesions using bisphosphonates with intralesional corticosteroid injections.Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease.

P2860

Q34162359-B05B749C-6BBE-4247-866F-3E8A2B4A294E Q34168384-433DB6F2-E6EB-4B32-8F29-91D120F16E57 Q34207408-E404BC02-C929-4E06-B855-6867F60EB526 Q34429959-C7E4C76B-7E1C-44D8-9F6D-830DF4407AE4 Q35282943-1F1E7B1D-04F2-4C0A-8C85-87073F3DAA80 Q35572441-E6449F3A-B147-4A06-9169-000937E541FF Q35755688-5B5B0C9B-5CFE-48E0-87C3-4C60B8563A50 Q35764778-52EC0C64-1B3C-4E0C-8549-889E673B01D1 Q35766784-8F42B236-D1C7-442F-B212-0C2558B70E97 Q35837168-A6F54CC9-9951-49F1-BC21-D35B7D1D785F Q35854092-B2307C17-8985-473A-BD5E-E39E2719A5C6 Q35910376-8A2CBB75-D8FB-421C-A5CC-5001FCBFD971 Q36182848-743EDF8C-44CE-473B-9E73-6E8D58D016D1 Q36253554-84979EB9-60F9-4D8A-AAF8-851C00963ACA Q36289023-4ADEA20A-FCDE-4A39-8829-C6C62C94B8E3 Q36299558-5339C06C-4BFB-4182-935C-640D5C543D0C Q36681335-CC1BC549-0B31-45A9-B665-25843BEF4B6B Q36753894-3E60ACF6-4FE0-4C3B-BAAA-4C1E27E39B9F Q36945036-864AE2E6-BCEC-4637-9AC3-905FEB502067 Q37006852-97A703B1-7D11-488C-B2E6-01B569B83BF3 Q37117104-5332C97A-6967-431F-8F56-93ADE7DFBFB8 Q37199204-B78D8160-10F9-4DED-9171-AD78E5997C1D Q37397269-6D2B3904-EA16-4249-9371-F8CA0451F6C7 Q37477690-9D956063-DAD6-40FF-9136-6631448F7D55 Q37615260-4639B56D-46BB-49F0-841D-C18A4D38DB57 Q37713115-1CCADD53-AF83-4194-8716-3846F9711118 Q38076462-8C4766E0-C1B5-4B3F-8888-ED1D2E338DBC Q38104993-7B7D55C3-37D0-468C-AD1C-35378697828E Q38184580-1D2E6836-5776-4E01-AB25-A8024EF45901 Q38438261-BA97AA4C-FAAB-4480-905F-AF7A08075CDE Q38472238-E4798AFA-C484-4561-9E46-4F284C3B0126 Q38803408-06FBBDAA-6329-434F-9167-76939B5FCEBC Q38848433-9C661081-82BE-4A2B-8CE1-C5BFFDDC1E29 Q38913031-8AC6846C-4810-4389-A082-560BD0EDE23E Q39314097-6ADB6E56-E48B-428A-9F24-9593AF2DC8CF Q39700905-8EAC04E9-336A-4399-9B1B-D7C926BA8CCC Q40293083-C45329E9-2C80-491B-AB4B-28F91CDA6E7C Q40605141-94808399-D7C2-4661-94C2-A07B66274F8D Q41474242-1B6F84EA-4032-4871-88D0-1775CC81E253 Q42202161-95A8A313-8B36-4BC4-ACD3-707695DDED01

P2860

Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.

http://www.wikidata.org/entity/Q33947252

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.

@ast

Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.

@en

type

label

Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.

@ast

Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.

@en

prefLabel

Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.

@ast

Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.

@en

P1433

Q33947252-837420EB-D9B7-43CF-A792-8B59EEDE6B4E

P1476

Q33947252-59B69A7B-F130-404B-B954-5395F019A5DB

P2093

Q33947252-093EB923-BAE0-49A7-954A-9AECC8E07BD5

Q33947252-1C232780-5740-45F9-93E4-09F26B65A9ED

Q33947252-33CFB0A8-ACB1-47A1-A6D6-C93EE14891A1

Q33947252-A26AE115-398B-4926-A593-BB8D569F4ACA

Q33947252-ACD6C1E4-84CC-4207-897C-1DF14071C5CF

Q33947252-B60101CF-78C7-4DC4-96AC-7C9F3C4072B7

Q33947252-D31343A9-79ED-4BF4-96BF-8383B271A995

Q33947252-FAD73FDA-78DA-455D-8F8C-77C8324CD518

P2860

Q33947252-07CFCB8E-0D2D-4459-ADD0-B5C4A1C53D97

Q33947252-0B2EFA69-A790-49EB-BC11-28BF5632FD61

Q33947252-324512E3-9303-431A-B240-AB75AAB3530A

Q33947252-338B4FFD-4AF4-4686-8243-446ECB80F8AF

Q33947252-34811938-8AA0-47AB-ABD3-8C92DDB479E3

Q33947252-4F6EA929-C80D-45B6-82D9-BD4467433D06

Q33947252-61890020-251A-409D-9CE4-0B3662DDF38F

Q33947252-6BAE24B6-D96D-443E-BDCA-3A9B42DF1655

Q33947252-6C562B37-FB66-4300-A6C9-FB0F4B38289B

Q33947252-75C0674A-B381-4077-9984-570E5FACBE64

P304

Q33947252-688167A7-A93C-46EB-90A2-CA62D40C2987

P31

Q33947252-59A42203-7E36-4FF8-925B-64C893BAA0FB

P356

Q33947252-4F086B18-D6C1-4720-9777-DC59EF40A3D2

P407

Q33947252-49E73A2B-3A91-4929-A1C2-44E9133504A8

P433

Q33947252-354310B8-06A1-4F1A-9059-6D354AB94734

P478

Q33947252-DCE99CC0-7582-4054-9CAE-D58E298BA67F

P577

Q33947252-CA67684C-4BA1-4BE2-94F9-16B6115097DE

P5875

Q33947252-F335B786-0406-45BA-914B-F9C76012BD45

P698

Q33947252-B5260808-6D3D-4C86-A966-3851172132C3

P932

Q33947252-FBBEF541-D65C-4373-AAEA-8D4594CEDB63

P356

AJPATH.2010.090592

P1433

The American Journal of Pathology

P1476

Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.

@en

P2093

Anh Le

http://www.w3.org/2001/XMLSchema#string

Chunzhang Cao

http://www.w3.org/2001/XMLSchema#string

Driss Ehirchiou

http://www.w3.org/2001/XMLSchema#string

Li Zhang

http://www.w3.org/2001/XMLSchema#string

Songtao Shi

http://www.w3.org/2001/XMLSchema#string

Takashi Kikuiri

http://www.w3.org/2001/XMLSchema#string

Yamei Gao

http://www.w3.org/2001/XMLSchema#string

Yanming Bi

http://www.w3.org/2001/XMLSchema#string

P2860

Giant osteoclast formation and long-term oral bisphosphonate therapy

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease.

Intravenous zoledronic acid in postmenopausal women with low bone mineral density.

Docetaxel: a review of its use in metastatic breast cancer.

Biophosphonate-related osteonecrosis of the jaws.

Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche.

Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage.

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

P304

280-290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2010.090592

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44602083

http://www.w3.org/2001/XMLSchema#string

P698

20472893

http://www.w3.org/2001/XMLSchema#string

P932

2893671

http://www.w3.org/2001/XMLSchema#string